Table 1 Clinical and pathological characteristics of patients with localized melanoma
From: Time-varying pattern of recurrence risk for localized melanoma in China
Characteristics | No. | % |
|---|---|---|
Age (years) | ||
Median | 53 | |
Range | 14-89 | |
Sex | ||
Male | 534 | 52.8 |
Female | 478 | 47.2 |
Clinical subtypes | ||
Acral | 400 | 39.5 |
CSD/non-CSD | 314 | 31.0 |
Mucosal | 298 | 29.4 |
Anatomic site for mucosal melanoma | ||
Head and neck | 188 | 63.1 |
Genitourinary tract | 64 | 21.5 |
Digestive tract | 42 | 14.1 |
Respiratory tract | 4 | 1.3 |
AJCC stage (for cutaneous melanoma only) | ||
I | 39 | 5.4 |
II | 361 | 50.6 |
III | 314 | 44.0 |
Ulceration (for cutaneous melanoma only) | ||
Present | 342 | 47.9 |
Absent | 372 | 52.1 |
Primary tumor thickness (for cutaneous melanoma only) | ||
≤ 4.0 mm | 228 | 31.9 |
> 4.0 mm | 354 | 49.6 |
Not available | 132 | 18.5 |
Regional lymph node metastasis (for cutaneous melanoma only) | ||
Yes | 400 | 56.0 |
No | 314 | 44.0 |
Wound infection after surgery (for cutaneous melanoma only) | ||
Yes | 69 | 9.7 |
No | 645 | 90.3 |
Adjuvant therapy for cutaneous melanoma | ||
Interferon a-2b | 246 | 34.5 |
Chemotherapy | 119 | 16.7 |
Radiotherapy | 3 | 0.4 |
None | 346 | 48.4 |
Adjuvant therapy for mucosal melanoma | ||
Chemotherapy | 47 | 15.8 |
Interferon a-2b | 41 | 13.8 |
Radiotherapy | 17 | 5.7 |
None | 193 | 64.8 |